CG
Column Group Portfolio holdings
AUM
$65.7M
This Quarter Return
+43.57%
1 Year Return
-5.8%
3 Year Return
-15.66%
5 Year Return
–
10 Year Return
–
AUM
$161M
AUM Growth
+$161M
(+6.1%)
Cap. Flow
-$458K
Cap. Flow
% of AUM
-0.29%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
Sagimet Biosciences
SGMT
|
$93.1K |
Top Sells
| 1 |
Oric Pharmaceuticals
ORIC
|
$377K |
| 2 |
Surrozen
SRZN
|
$175K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tenaya Therapeutics
TNYA
$184M
| $49.2M | 30.62% | 9,400,290 | – | – |
|
|
2
Oric Pharmaceuticals
ORIC
$994M
| $48.7M | 30.33% | 3,540,777 -27,404 | -0.8% | -$377K |
|
|
NGM
3
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $28.8M | 17.96% | 18,136,735 | – | – |
|
4
RAPT Therapeutics
RAPT
$188M
| $24.1M | 14.99% | 2,680,621 | – | – |
|
|
5
Surrozen
SRZN
$104M
| $9.69M | 6.03% | 616,540 -11,111 | -2% | -$175K |
|
|
6
Sagimet Biosciences
SGMT
$244M
| $93.1K | 0.06% | +17,169 | New | +$93.1K |
|
7
Revolution Medicines
RVMD
$7.1B
| $1.48K | ﹤0.01% | 46 | – | – |
|